![]() |
Volumn 28, Issue 27, 2010, Pages 4149-4153
|
Continental divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
NEW DRUG;
ARTICLE;
CANADA;
CLINICAL DECISION MAKING;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
FEMALE;
HEALTH CARE ACCESS;
HEALTH CARE POLICY;
HEALTH CARE SYSTEM;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PHYSICIAN ATTITUDE;
PRIORITY JOURNAL;
UNITED STATES;
ATTITUDE TO HEALTH;
CHI SQUARE DISTRIBUTION;
CLINICAL PRACTICE;
COMPARATIVE STUDY;
COST;
COST BENEFIT ANALYSIS;
DOCTOR PATIENT RELATION;
ECONOMICS;
HEALTH CARE DELIVERY;
HEALTH CARE SURVEY;
HEALTH INSURANCE;
HEALTH PERSONNEL ATTITUDE;
INSURANCE;
LEGAL ASPECT;
ONCOLOGY;
PHYSICIAN;
PRACTICE GUIDELINE;
PSYCHOLOGICAL ASPECT;
ANTINEOPLASTIC AGENTS;
ATTITUDE OF HEALTH PERSONNEL;
CANADA;
CHI-SQUARE DISTRIBUTION;
COST SHARING;
COST-BENEFIT ANALYSIS;
DRUG COSTS;
DRUGS, INVESTIGATIONAL;
FEMALE;
HEALTH CARE SURVEYS;
HEALTH KNOWLEDGE, ATTITUDES, PRACTICE;
HEALTH POLICY;
HEALTH SERVICES ACCESSIBILITY;
HUMANS;
INSURANCE COVERAGE;
INSURANCE, HEALTH;
MALE;
MEDICAL ONCOLOGY;
PHYSICIAN'S PRACTICE PATTERNS;
PHYSICIAN-PATIENT RELATIONS;
PHYSICIANS;
PRACTICE GUIDELINES AS TOPIC;
UNITED STATES;
|
EID: 77957956574
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2010.29.1625 Document Type: Article |
Times cited : (59)
|
References (15)
|